AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Bradda Head Lithium Ltd.

Management Reports Apr 4, 2025

14841_dirs_2025-04-04_5c66b2ec-7a91-4f36-8f0b-24c816f3b26f.html

Management Reports

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 6086D

Bradda Head Lithium Ltd

04 April 2025

Logo, company name Description automatically generated 4 April 2025

Bradda Head Lithium Ltd

("Bradda Head", "BHL" or the "Company")

Repricing and Extension of Share Options

Extension of Share Warrants

Bradda Head Lithium Ltd (AIM:BHL), the North America-focused lithium development group, announces the repricing of 8,350,000 outstanding share options ("Existing Options"); such Existing Options representing 2.14% of the Company's current issued share capital.

The repricing applies to Existing Options previously granted to certain Directors and Management of the Company pursuant to the Company's share option plan, as follows:

Name Issue date Existing Options exercise price Number
Promaco Limited* Sep-21 £0.090 1,250,000
Piotr Schabik Sep-21 £0.090 250,000
Promaco Limited* Apr-22 £0.180 3,000,000
Alex Borrelli Dec-22 £0.105 500,000
Euan Jenkins Dec-22 £0.105 500,000
Promaco Limited* Apr-23 £0.060 1,000,000
Joey Wilkins Apr-23 £0.060 1,500,000
Piotr Schabik Apr-23 £0.060 250,000
Ian Christianson Apr-23 £0.060 100,000
Total options 8,350,000

* Promaco Limited is a company owned by a trust of which Ian Stalker, Chair, is a beneficiary

The Existing Options will be repriced from various existing exercise prices of £0.06, £0.09, £0.105, and £0.18 per ordinary share to £0.015 (1.5 pence) per common share, being a premium of 30% to the closing share price on 2 April 2025 of £0.0115 (1.15 pence) and a premium of 7% to the 12 month VWAP. The repricing does not affect the Existing Options' current vesting schedules, if applicable, and does not extend the term of the Existing Options. The repricing is being taken in response to the current market challenges impacting the lithium sector, a resulting reduction in the Company's share price, and to better align with the recent share options granted to certain officers and directors at a price of £0.015 (1.5 pence). Whilst the Directors recognise the decline in the share price, they feel that incentivising Directors and Management is important, particularly recognising the reduced corporate overhead the Company is focused on.

In addition, the exercise periods of certain Share Options awarded during June 2021 and September 2021 have been extended for an additional period of 2 years, with the exercise period now being 7 years from grant date. Following the extension, a total of 15,000,000 Share Options have an exercise period up to June 2028, and a further 1,500,000 Share Options have an exercise period of September 2028.

Extension of Warrants Exercise Period

The Company has also extended the exercise period of Share Warrants awarded to Beaumont Cornish Limited, nominated advisor to the Company, for an additional period of 2 years. A total of 1,818,182 Share Warrants were awarded to Beaumont Cornish as part of the AIM listing in July 2021. The exercise period of these Share Warrants has been extended to 19 July 2028, but these remain exercisable at the original exercise price of £0.055 (5.5 pence).

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014, as it forms part of  UK  Domestic Law by virtue of the  European Union  (Withdrawal) Act 2018. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

ENDS

Bradda Head Lithium Limited Beaumont Cornish Panmure Liberum Shard Capital Tavistock
Company Nomad Joint Broker Joint Broker Investor Relations
Ian Stalker, Executive Chair

Denham Eke, Finance Director
James Biddle /

Roland Cornish
Rauf Munir Damon Heath / Isabella Pierre Nick Elwes /

Josephine Clerkin
+44 1624 639 396 +44 20 7628 3396 +44 20 7886 2500 +44 207 186 9927 + 44 20 7920 3150

[email protected]

About Bradda Head Lithium Ltd.

Bradda Head Lithium Ltd. is a North America-focused lithium development group. The Company currently has interests in a variety of projects, the most advanced of which are in Central and Western Arizona: The Basin Project (Basin East Project, and the Basin West Project) and the Wikieup Project.

The Basin East Project has a Measured Mineral Resource of 20 Mt at an average grade of 929 ppm Li for a total of 99 kt LCE and an Indicated Mineral Resource of 122 Mt at an average grade of 860 ppm Li and an Inferred Mineral Resource of 499 Mt at an average grade of 810 ppm Li for a total of 2.81 Mt LCE. The Group intends to continue to develop its three phase one projects in Arizona, whilst endeavouring to unlock value at its other prospective pegmatite and brine assets in Arizona, Nevada, and Pennsylvania. All of Bradda Head's licences are held on a 100% equity basis and are in close proximity to the required infrastructure. Bradda Head is quoted on the AIM of the London Stock Exchange with the ticker of BHL.

Forward-Looking Statements

Beaumont Cornish Limited ("Beaumont Cornish") is the Company's Nominated Adviser and is authorised and regulated by the FCA. Beaumont Cornish's responsibilities as the Company's Nominated Adviser, including a responsibility to advise and guide the Company on its responsibilities under the AIM Rules for Companies and AIM Rules for Nominated Advisers, are owed solely to the London Stock Exchange. Beaumont Cornish is not acting for and will not be responsible to any other persons for providing protections afforded to customers of Beaumont Cornish nor for advising them in relation to the proposed arrangements described in this announcement or any matter referred to in it.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHEASLDESXSEFA

Talk to a Data Expert

Have a question? We'll get back to you promptly.